Nature News highlights: 31 January 2012

Can't view this email? Click here to view in your browser.     31 January 2012       nature news alert • Read Nature's news online • Subscribe to Nature Your weekly update from Nature's global news team.                       BD Accuri® C6 personal flow cytometer The BD Accuri C6 gives you 4-color cell analysis in an affordable, transportable, and easy-to-use format, putting flow cytometry within reach for both novice and experienced researchers. BD CFlow® software's intuitive interface guides you through workflows, making it easy to begin collecting and analyzing data. Learn more today at bdbiosciences.com/go/accuri               • Featured               Special: Mutant Flu ▶       Scientists have created a form of the H5N1 avian flu virus that is transmissible between mammals, raising fears that it could trigger a human pandemic if it escapes from the lab – either through accidental release or as part of a bioterror attack. As debate rages over how much of the research should be published, and whether there is sufficient oversight of such work, you can follow all Nature's coverage of the issue here. Read More ▶                   • Latest News               Study measures mammalian growth spurt ▶ 30 January 2012     It takes 24 million generations for mouse-sized mammals to evolve into elephants - but shrinking back is much faster. Read More ▶             Cancer drugs affect mouse genomes for generations  ▶ 30 January 2012     DNA mutations continue to accumulate in offspring of treated mice. Read More ▶             Road map unveiled to tackle neglected diseases ▶ 30 January 2012     The WHO hopes to control or eliminate ten diseases by 2020. Read More ▶                         Nature Immunology presents a webcast series on Current Controversies Webcasts now available free on demand on the following topics: Lineage Differentiation HIV Vaccines Human Immunology Sponsored by: STEMCELL TECHNOLOGIES               • More Stories               Informed consent on trial ▶ 30 January 2012     Lengthy, complicated documents leave many clinical-trial participants in the dark about the risks they face. Read More ▶             Paper denying HIV-AIDS link sparks resignation ▶ 30 January 2012     Member of editorial board quits as editor defends publication. Read More ▶             Democracy isn't all it is cracked up to be ▶ 27 January 2012     Statistical analysis can reveal election fraud, a paper says. But the problems with democracy go deeper, argues Philip Ball. Read More ▶             Science reborn in Tunisia ▶ 27 January 2012     Academics are cautiously optimistic on anniversary of revolution. Read More ▶             Russian physicists protest government consolidation ▶ 27 January 2012     Restrictive policies are affecting international collaboration. Read More ▶             Satellite controversy bubbles over for Indian space agency ▶ 27 January 2012     Four former administrators barred from government work. Read More ▶             Researchers defend benefits of mutant flu research ▶ 26 January 2012     A dire lack of global virus surveillance doesn't negate the potential of mutation monitoring, argue two researchers behind the mutant flu research. Read More ▶             A shaky future for Hispaniola ▶ 26 January 2012     2010 Haiti quake may portend increased seismic activity in coming decades. Read More ▶             Prion diseases hide out in the spleen ▶ 26 January 2012     UK population could harbour thousands of silent infections. Read More ▶             Flooding is the United Kingdom's biggest climate threat ▶ 26 January 2012     Government report prioritizes consequences of climate change. Read More ▶             Innovation is 'imperative', says Brazil science minister ▶ 25 January 2012     But new appointee must reverse last year's budget cuts. Read More ▶             Going paperless: The digital lab ▶ 25 January 2012     Lab-management software and electronic notebooks are here - and this time, it's more than just talk. Read More ▶               • Newsblog               Read up to the minute coverage of research and science policy. FDA employees sue agency over email surveillance Sharif University faculty protest US arrest Engine trouble scuttles plans for Arctic research expedition F1000 launches fast, open science publishing for biology and medicine Visiting Iranian scientist falls foul of US authorities Europe prepares to admit that biodiesel is worse than fossil fuels Kepler uncovers planetary menagerie US physicists call for underground neutrino facility Answer found for cancer drug failure 'Newt Skywalker? aims for the Moon and Mars more...                           Nature Reviews Cancer POSTER - Proteasome inhibition and cancer therapy Author: Q. Ping Dou This poster highlights recent achievements and progress in targeting the ubiquitin-proteasome degradation pathway for cancer therapy. Access the Poster FREE online! www.nature.com/nrc/posters/proteasome This Poster is freely available thanks to sponsorship from Onyx Pharmaceuticals, Inc.                     • Jobs           naturejobs.com Science jobs of the week       PhD Openings in NanoBioTechnology     Ludwig-Maximilians-University Munich            Research Assistant     Mount Sinai School of Medicine (Lira Lab)            Health Economics Associate     Redford Stone            Marketing Manager - Medical Device     Prime Pharma            Investigator Scientist     Medical Research Council          No matter what your career stage, student, postdoc or senior scientist, you will find articles on naturejobs.com to help guide you in your science career. Keep up-to-date with the latest sector trends, vote in our reader poll and sign-up to receive the monthly Naturejobs newsletter.                   Your email address is in the Nature News Weekly Alert mailing list. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact subscriptions@nature.com For print subscription enquiries, please contact feedback@nature.com Nature Publishing Group | 75 Varick Street, 9th floor | New York | NY 10013-1917 | USA Nature Publishing Group's offices: Principal offices: London - New York - Tokyo Worldwide offices: Basingstoke - Boston - Buenos Aires - Delhi - Hong Kong - Madrid - Melbourne - Munich - Paris - San Francisco - Seoul - Washington DC Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2012 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.